Factors associated with dose reduction of pirfenidone in patients with idiopathic pulmonary fibrosis: a study based on real-world clinical data

HIGHLIGHTS

• who: Jiwon Kim and collaborators from the Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan have published the article: Factors associated with dose reduction of pirfenidone in patients with idiopathic pulmonary fibrosis: A study based on real-world clinical data, in the Journal: PLOS ONE of January/19,/2023
• what: The authors aimed to investigate clinical characteristics of and factors associated with dose reduction of pirfenidone in a real-world setting. The authors compared changes in FVC and DLCO between the standard and low-dose groups and found no . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.